Norden Group LLC Buys New Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Norden Group LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, Holdings Channel.com reports. The fund purchased 10,637 shares of the company’s stock, valued at approximately $358,000.

Several other hedge funds and other institutional investors have also modified their holdings of OPCH. Securian Asset Management Inc. increased its position in Option Care Health by 3.4% during the 3rd quarter. Securian Asset Management Inc. now owns 15,235 shares of the company’s stock worth $493,000 after purchasing an additional 503 shares in the last quarter. Alliance Wealth Advisors LLC UT lifted its position in Option Care Health by 7.7% during the third quarter. Alliance Wealth Advisors LLC UT now owns 11,234 shares of the company’s stock valued at $363,000 after buying an additional 802 shares in the last quarter. State of Alaska Department of Revenue grew its stake in Option Care Health by 4.3% during the third quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company’s stock worth $691,000 after buying an additional 880 shares during the period. Tower Research Capital LLC TRC increased its position in shares of Option Care Health by 11.0% in the third quarter. Tower Research Capital LLC TRC now owns 9,190 shares of the company’s stock worth $297,000 after acquiring an additional 913 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its stake in shares of Option Care Health by 9.7% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 10,855 shares of the company’s stock valued at $351,000 after acquiring an additional 957 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of research reports. Jefferies Financial Group upped their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 24th.

Option Care Health Price Performance

Shares of OPCH stock opened at $29.98 on Thursday. The firm has a fifty day simple moving average of $31.75 and a 200-day simple moving average of $31.44. The company has a market capitalization of $5.21 billion, a PE ratio of 19.72, a price-to-earnings-growth ratio of 1.45 and a beta of 1.26. Option Care Health, Inc. has a twelve month low of $24.23 and a twelve month high of $35.74. The company has a current ratio of 1.77, a quick ratio of 1.39 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The company had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the company posted $0.21 EPS. The firm’s revenue for the quarter was up 12.8% on a year-over-year basis. Equities research analysts anticipate that Option Care Health, Inc. will post 1.19 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The stock was acquired at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the purchase, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.